Related Experiment Videos
Bile acids in experimental colorectal cancer
Summary
Bile acids like sodium deoxycholate (SDC) promote colorectal cancer by increasing cell growth in the intestine, but only when gut bacteria are present. Metronidazole reduced this effect, suggesting a role for fecal anaerobes.
Area of Science:
- Gastroenterology
- Oncology
- Microbiology
Background:
- Epidemiological and experimental evidence suggests bile acids act as endogenous co-carcinogens in colorectal cancer.
- Sodium deoxycholate (SDC) is a primary bile acid implicated in this process.
Purpose of the Study:
- To investigate the role of SDC in promoting intestinal hyperplasia and neoplasia in a rat model.
- To explore the intermediary role of fecal anaerobes in SDC-induced colorectal carcinogenesis.
Main Methods:
- Intrarectal instillation of SDC in rats (n=265).
- Administration of oral metronidazole to assess the role of fecal anaerobes.
- Comparison of SDC effects in functioning large bowel versus an isolated Thiry-Vella fistula model.
Main Results:
- Intrarectal SDC administration significantly increased tumor yield, crypt depth, and crypt cell production rate in the functioning large bowel.
- Metronidazole treatment reduced SDC-induced tumor promotion but did not affect SDC-induced hyperplasia.
- SDC showed no tumor-promoting activity in the isolated colon (Thiry-Vella fistula).
Conclusions:
- Bile acids, specifically SDC, promote colorectal carcinogenesis primarily by stimulating mucosal hyperplasia.
- The presence of fecal matter and associated anaerobes is crucial for bile acid-mediated tumor promotion in the colon.
- Targeting gut microbiota may offer a strategy to mitigate bile acid-driven colorectal cancer risk.